Published in
Elsevier, Leukemia Research, (110), p. 106707, 2021
DOI: 10.1016/j.leukres.2021.106707
Links
Tools
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia
Journal article published in 2021 by
Hetty E. Carraway,
Yazeed Sawalha,
Ivana Gojo,
Min-Jung Lee,
Sunmin Lee 
,
Yusuke Tomita ,
Akira Yuno,
Jackie Greer ,
B. Douglas Smith,
Keith W. Pratz,
Mark J. Levis,
Steven D. Gore,
Nilanjan Ghosh,
Amy Dezern,
Amanda L. Blackford
and other authors.
,
Yusuke Tomita ,
Akira Yuno,
Jackie Greer ,
B. Douglas Smith,
Keith W. Pratz,
Mark J. Levis,
Steven D. Gore,
Nilanjan Ghosh,
Amy Dezern,
Amanda L. Blackford
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 